ESC 365 - Assistant Professor Alexander Peikert

Speaker illustration

Assistant Professor Alexander Peikert

Medical University of Graz, Graz (Austria)

Member of:

European Society of Cardiology

Presentations Articles

Effect of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction treated with beta-blockers: the DELIVER trial

Event: ESC Congress 2023

Topic: Pharmacotherapy

Session: State-of-the art treatment of HFmrEF and HFpEF in 2023

Efficacy and safety of dapagliflozin in the background of polypharmacy among patients with HFmrEF and HFpEF in the DELIVER trial

Event: Heart Failure 2023

Topic: Pharmacotherapy

Session: Chronic heart failure - pharmacotherapy 4

Effect of dapagliflozin on individual components of the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial

Event: Heart Failure 2023

Topic: Pharmacotherapy

Session: Chronic heart failure - pharmacotherapy 2

Need of Treating Residual Inflammatory Activity in Coronary Heart Disease: the value of high sensitive CRP and LDL in a Real World Cohort.

Event: ESC Congress 2018

Topic: Inflammation and Immunity

Session: Inflammation and immunity in acute coronary syndromes

ESC 365 is supported by

novartis

Explore sponsored resources